ArticleJournal of medicinal chemistry2022

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.

Yuto Unoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.